Rosemary Yu

Rosemary Yu

Auto-generated profile, based on publicly available information

Rosemary Yu

Department of Molecular Developmental Biology, Radboud Institute for Molecular Life Sciences, Faculty of Science, Radboud University, 6525GA Nijmegen, the Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2016 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PMPeter J. Mullen
Peter J. Mullen
RYRosemary Yu
Rosemary Yu
JLJoseph Longo
Joseph Longo
MAMichael C. Archer
Michael C. Archer
LPLinda Z. Penn
Linda Z. Penn

13 December 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CMCarl Malina
Carl Malina
RYRosemary Yu
Rosemary Yu
JBJohan Björkeroth
Johan Björkeroth
EKEduard Kerkhoven
Eduard Kerkhoven
JNJens Nielsen
Jens Nielsen
Aerobic fermentation, also referred to as the Crabtree effect in yeast, is a well-studied phenomenon that allows many eukaryal cells to attain higher growth rates at high glucose availability. Not all yeasts exhibit the Crabtree effect, and it is not known why Crabtree-negative yeasts can grow at rates comparable to Crabtree-positive yeasts. Here, we quantitatively compared two Crabtree-positive yeasts, Saccharomyces cerevisiae and Schizosaccharomyces pombe, and two Crabtree-negative yeasts, Kluyveromyces marxianus and Scheffersomyces stipitis, cultivated under glucose excess conditions. Combining physiological and proteome quantification with genome-scale metabolic modeling, we found that the two groups differ in energy metabolism and translation efficiency. In Crabtree-positive yeasts, the central carbon metabolism flux and proteome allocation favor a glucose utilization strategy minimizing proteome cost as proteins translation parameters, including ribosomal content and/or efficiency, are lower. Crabtree-negative yeasts, however, use a strategy of maximizing ATP yield, accompanied by higher protein translation parameters. Our analyses provide insight into the underlying reasons for the Crabtree effect, demonstrating a coupling to adaptations in both metabolism and protein translation. Significance Overflow metabolism, referred to as the Crabtree effect in yeast, is the seemingly wasteful strategy of using aerobic fermentation instead of the more efficient respiration for energy generation. This allows cells to grow faster at high glucose availability. Although well-studied, the underlying reasons that not all yeasts experience the Crabtree effect while still able to grow at comparable rates as yeasts exhibiting the effect, are not known. We combined physiological and proteome quantification with metabolic modeling to perform a quantitative comparison of four yeasts, two exhibiting and two not exhibiting the Crabtree effect, under glucose excess conditions. Our analyses provide insight into the underlying causes of the Crabtree effect, demonstrating a coupling to adaptations in both metabolism and protein translation.

1 September 2014 in Cancer Research
Verified
Journal Article
Closed access
PDF file
APAleksandra Pandyra
Aleksandra Pandyra
PMPeter J. Mullen
Peter J. Mullen
MKManpreet Kalkat
Manpreet Kalkat
RYRosemary Yu
Rosemary Yu
JPJanice T. Pong
Janice T. Pong
LPLinda Z. Penn
Linda Z. Penn
New therapies are urgently needed for hematologic malignancies, especially in patients with relapsed acute myelogenous leukemia (AML) and multiple myeloma. We and others have previously shown that FDA-approved statins, which are used to control hypercholesterolemia and target the mevalonate pathway (MVA), can trigger tumor-selective apoptosis. Our goal was to identify other FDA-approved drugs that synergize with statins to further enhance the anticancer activity of statins in vivo. Using a screen composed of other FDA approved drugs, we identified dipyridamole, used for the prevention of cerebral ischemia, as a potentiator of statin anticancer activity. The statin–dipyridamole combination was synergistic and induced apoptosis in multiple myeloma and AML cell lines and primary patient samples, whereas normal peripheral blood mononuclear cells were not affected. This novel combination also decreased tumor growth in vivo. Statins block HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the MVA pathway. Dipyridamole blunted the feedback response, which upregulates HMGCR and HMG-CoA synthase 1 (HMGCS1) following statin treatment. We further show that dipyridamole inhibited the cleavage of the transcription factor required for this feedback regulation, sterol regulatory element–binding transcription factor 2 (SREBF2, SREBP2). Simultaneously targeting the MVA pathway and its restorative feedback loop is preclinically effective against hematologic malignancies. This work provides strong evidence for the immediate evaluation of this novel combination of FDA-approved drugs in clinical trials. Cancer Res; 74(17); 4772–82. ©2014 AACR.

5 November 2010 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
TDTao Dong
Tao Dong
RYRosemary Yu
Rosemary Yu
HSHerb Schellhorn
Herb Schellhorn
Summary: Bacteria generally possess multiple σ factors that, based on structural and functional similarity, divide into two families: σ70 and σN. Many studies have revealed σ factor competition within the σ70 family, while the competition between σN and σ70 families has yet to be fully explored. Here we report a global antagonistic effect on gene expression between two alternative σ factors, σN (RpoN) and a σ70 family protein σS (RpoS). Mutations in rpoS and rpoN were found to inversely affect a number of cellular traits, such as the expression of flagellar genes, σN‐controlled growth on poor nitrogen sources, and σS‐directed expression of acid phosphatase AppA. Transcriptome analysis reveals that about 60% of genes in the RpoN regulon are under reciprocal RpoS control. Furthermore, loss of RpoN led to increased levels of RpoS, while RpoN levels were unaffected by the rpoS mutation. Expression of the flagellar σF factor (FliA), another σ70 family protein, is controlled positively by RpoN but negatively by RpoS. This positive control by RpoN is likely mediated through the flagellar regulator FlhDC, whose expression is RpoN‐dependent. These findings unveil a complex regulatory interaction among σN, σS and σF, which modulates motility, nitrogen utilization, stress response and many other cellular functions.

20 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
RYRosemary Yu
Rosemary Yu
KCKate Campbell
Kate Campbell
RPRui Pereira
Rui Pereira
JBJohan Björkeroth
Johan Björkeroth
QQQi Qi
Qi Qi
JNJens Nielsen
Jens Nielsen
Cells maintain reserves in their metabolic and translational capacities as a strategy to quickly respond to changing environments. Here we quantify these reserves by stepwise reducing nitrogen availability in yeast steady-state chemostat cultures, imposing severe restrictions on total cellular protein and transcript content. Combining multi-omics analysis with metabolic modeling, we find that seven metabolic superpathways maintain >50% metabolic capacity in reserve, with glucose metabolism maintaining >80% reserve capacity. Cells maintain >50% reserve in translational capacity for 2490 out of 3361 expressed genes (74%), with a disproportionately large reserve dedicated to translating metabolic proteins. Finally, ribosome reserves contain up to 30% sub-stoichiometric ribosomal proteins, with activation of reserve translational capacity associated with selective upregulation of 17 ribosomal proteins. Together, our dataset provides a quantitative link between yeast physiology and cellular economics, which could be leveraged in future cell engineering through targeted proteome streamlining.

1 July 2019 in Molecular Metabolism
Verified
Journal Article
Open access
JLJoseph Longo
Joseph Longo
PMPeter J. Mullen
Peter J. Mullen
RYRosemary Yu
Rosemary Yu
JLJenna E. van Leeuwen
Jenna E. van Leeuwen
MMMehdi Masoomian
Mehdi Masoomian
LPLinda Z. Penn
Linda Z. Penn
The statin family of cholesterol-lowering drugs has been shown to induce tumor-specific apoptosis by inhibiting the rate-limiting enzyme of the mevalonate (MVA) pathway, HMG-CoA reductase (HMGCR). Accumulating evidence suggests that statin use may delay prostate cancer (PCa) progression in a subset of patients; however, the determinants of statin drug sensitivity in PCa remain unclear. Our goal was to identify molecular features of statin-sensitive PCa and opportunities to potentiate statin-induced PCa cell death. Deregulation of HMGCR expression in PCa was evaluated by immunohistochemistry. The response of PCa cell lines to fluvastatin-mediated HMGCR inhibition was assessed using cell viability and apoptosis assays. Activation of the sterol-regulated feedback loop of the MVA pathway, which was hypothesized to modulate statin sensitivity in PCa, was also evaluated. Inhibition of this statin-induced feedback loop was performed using RNA interference or small molecule inhibitors. The achievable levels of fluvastatin in mouse prostate tissue were measured using liquid chromatography-mass spectrometry. High HMGCR expression in PCa was associated with poor prognosis; however, not all PCa cell lines underwent apoptosis in response to treatment with physiologically-achievable concentrations of fluvastatin. Rather, most cell lines initiated a feedback response mediated by sterol regulatory element-binding protein 2 (SREBP2), which led to the further upregulation of HMGCR and other lipid metabolism genes. Overcoming this feedback mechanism by knocking down or inhibiting SREBP2 potentiated fluvastatin-induced PCa cell death. Notably, we demonstrated that this feedback loop is pharmacologically-actionable, as the drug dipyridamole can be used to block fluvastatin-induced SREBP activation and augment apoptosis in statin-insensitive PCa cells. Our study implicates statin-induced SREBP2 activation as a PCa vulnerability that can be exploited for therapeutic purposes using clinically-approved agents.